MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation
Clinical trial NCT04967287 · COMPLETED
Trial details
- NCT number
- NCT04967287
- Sponsor
- Dopavision GmbH
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2024-10-04
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.